29 Emmons Dr
Princeton, NJ 08540

Soligenix News

Soligenix CEO discusses biodefense activity with DDNews

Friday, Sep 11, 2015 @ 8:39pm by BioPrepWatch Reports

Soligenix Inc. CEO and President Christopher Schaber recently gave an interview with DDNews during which he discussed the company's therapeutics and biological defense business activities.
Read More »

Soligenix awarded additional ricin vaccine funding

Thursday, Aug 20, 2015 @ 6:15pm by BioPrepWatch Reports

Soligenix, Inc. has received an additional $2.7 million from the National Institute of Allergy and Infectious Diseases (NIAID) in order to continue development of their ricin vaccine, the company announced Wednesday.
Read More »

Soligenix agrees to $10 million equity agreement

Monday, Aug 3, 2015 @ 3:37pm by BioPrepWatch Reports

Soligenix, Inc. announced on Monday that it has entered into an equity purchase agreement with Kodiak Capital Group,LLC; River North Equity, LLC and Kingsbrook Opportunities Master Fund LP.
Read More »